Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Physiological Changes in Conn Syndrome (Primary Aldosteronism)

Pathophysiology of Conn Syndrome

  • The American College of Cardiology notes that elevated aldosterone levels with suppressed renin activity, typically resulting in an aldosterone-to-renin ratio greater than 30, are characteristic of Conn syndrome 2, 3
  • Sodium retention and potassium excretion due to excessive aldosterone production occur in patients with Conn syndrome 2
  • Hypertension is a classic presentation of Conn syndrome, as seen in a 25-year-old woman with high blood pressure 1, 3
  • Hypokalemia is often present, causing weakness and metabolic alkalosis in patients with Conn syndrome 2, 4

Specific Physiological Changes

Sodium and Volume Handling

  • Increased extracellular fluid volume due to sodium retention mediated by aldosterone's action on the distal tubule occurs in Conn syndrome 2
  • Increased effective circulating volume as a result of sodium and water retention is a physiological change in Conn syndrome 2
  • Decreased proximal tubule Na+ reabsorption occurs as a compensatory response to the volume expansion in Conn syndrome 2

Clinical Correlation

  • A patient with Conn syndrome typically presents with hypertension, high aldosterone level, and an adrenal mass on imaging 1, 2, 3

Diagnostic Approach

  • Measuring plasma aldosterone and renin activity is involved in the diagnosis of primary aldosteronism 2
  • Confirmatory testing with saline suppression or salt loading tests is used to diagnose primary aldosteronism 2
  • Imaging of the adrenal glands to identify adenomas is a diagnostic step for primary aldosteronism 2
  • Adrenal vein sampling to confirm lateralization, especially in patients over 40 years, is a diagnostic consideration for primary aldosteronism 2

Treatment Considerations

  • Laparoscopic adrenalectomy is the treatment of choice for unilateral aldosterone-producing adenomas 2
  • Medical management with mineralocorticoid receptor antagonists, such as spironolactone or eplerenone, is used for bilateral disease or non-surgical candidates 2

REFERENCES

1

neuroendocrine tumors. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

2

neuroendocrine tumors. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

3

neuroendocrine tumors. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

4

neuroendocrine tumors. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012